These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15686728)

  • 1. Monitoring of T-cell repertoire was useful for predicting graft-versus-host disease prognosis in a patient with chronic myelogeneous leukemia after allogeneic bone marrow transplantation.
    Tsutsumi Y; Tanaka J; Minami H; Musashi M; Fukushima A; Kawamura T; Kanamori H; Obara S; Noto S; Ogura N; Asaka M; Imamura M; Masauzi N
    Transplant Proc; 2004 Dec; 36(10):3200-2. PubMed ID: 15686728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Donor leukocyte transfusion in a patient with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation: analysis of natural killer cell activity and T-cell receptor repertoire in bone marrow T cells that exhibited graft-versus-leukemia activity].
    Suehiro Y; Muta K; Umemura T; Motomura S; Nishimura J; Nawata H; Kimura N
    Rinsho Ketsueki; 1999 Jan; 40(1):40-5. PubMed ID: 10067095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association with the presence of naive T cells in chronic myeloid leukemia patients after allogeneic human stem cell transplantation and the lower incidence of chronic graft-versus host disease and relapse.
    Wysoczanska B; Bogunia-Kubik K; Dlubek D; Jaskula E; Sok A; Drabczak-Skrzypek D; Sedzimirska M; Lange A
    Transplant Proc; 2007 Nov; 39(9):2898-901. PubMed ID: 18022011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe isolated acute hepatic graft-versus-host disease with vanishing bile duct syndrome.
    Yeh KH; Hsieh HC; Tang JL; Lin MT; Yang CH; Chen YC
    Bone Marrow Transplant; 1994 Aug; 14(2):319-21. PubMed ID: 7994249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B; Li DP; Xu KL; Pan XY
    Chin Med J (Engl); 2005 Mar; 118(6):474-9. PubMed ID: 15788128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell large granular lymphocyte leukemia of donor origin after allogeneic bone marrow transplantation.
    Au WY; Lam CC; Lie AK; Pang A; Kwong YL
    Am J Clin Pathol; 2003 Oct; 120(4):626-30. PubMed ID: 14560574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
    Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory chronic GVHD emerging after splenectomy in a marrow transplant recipient with accelerated phase CML.
    Rodrigues CA; Fermino FA; Vasconcelos Y; de Oliveira JS
    Bone Marrow Transplant; 2003 Aug; 32(3):333-5. PubMed ID: 12858207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy.
    Adkins DR; Abidi MH; Brown RA; Khoury H; Goodnough LT; Vij R; Westervelt P; DiPersio JF
    Bone Marrow Transplant; 2000 Dec; 26(11):1239-41. PubMed ID: 11149740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report.
    Mohty M; Faucher C; Gaugler B; Vey N; Sainty D; Arnoulet C; Mozziconacci MJ; Isnardon D; Gastaut JA; Maraninchi D; Olive D; Blaise D
    Bone Marrow Transplant; 2001 Dec; 28(12):1157-60. PubMed ID: 11803360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Nonmyleoablative allogeneic stem cell transplantation combined with imatinib in treatment of chronic myeloid leukemia: a clinical study].
    Liu L; Liu Q; Hao MW; Chen RA; Zhang JL; Wang LH; He H; Jiang SS; Liang YM
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(16):1102-5. PubMed ID: 16029566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism.
    Wu CJ; Chillemi A; Alyea EP; Orsini E; Neuberg D; Soiffer RJ; Ritz J
    Blood; 2000 Jan; 95(1):352-9. PubMed ID: 10607724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case with myositis as a manifestation of chronic graft-versus-host-disease (GVHD) with severe muscle swelling developed after aggressive muscular exercise].
    Kano S; Shimizu J; Mikata T; Shinoe T; Ota H; Komeno Y; Ogawa S; Hirai H; Kanazawa I
    Rinsho Shinkeigaku; 2003 Mar; 43(3):93-7. PubMed ID: 12820556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
    Kanamori H; Tanaka M; Kawaguchi H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
    Am J Hematol; 2002 Sep; 71(1):41-4. PubMed ID: 12221673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Basedow disease occurring after allogeneic bone marrow transplantation for acute lymphoblastic leukemia].
    Sasaki Y; Ito K
    Rinsho Ketsueki; 2002 Sep; 43(9):833-5. PubMed ID: 12412287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.